XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 1 - Organization and Description of Business
12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
Nature of Operations [Text Block]

1. Organization and Description of Business

 

Diffusion Pharmaceuticals Inc. ("the Company"), a Delaware corporation, is a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most. The Company’s lead product candidate, TSC, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. In November 2021, based on the preclinical and clinical data accumulated to date and the significant unmet medical need, the Company announced that its near-term focus will be the design and execution of a clinical program to support the use of intravenously administered TSC as an adjunctive treatment for hypoxic solid tumors.